The reverse propensity score to detect selection bias and correct for baseline imbalances

Statistics in Medicine

Volumn 24, Issue 18, 2005, Pages 2777-2787

  Berger, Vance W ^a,b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF MARYLAND BALTIMORE COUNTY   (United States)

Author keywords

Allocation concealment; Balancing score; Covariate adjustment; Randomized clinical trials

Indexed keywords

ANALYTIC METHOD; ARTICLE; BREAST CANCER; CANCER SCREENING; CLINICAL RESEARCH; DIAGNOSTIC VALUE; HUMAN; MAMMOGRAPHY; MEDICAL DECISION MAKING; OUTCOMES RESEARCH; PATIENT SELECTION; POPULATION DISTRIBUTION; PROBABILITY; PROGNOSIS; RANDOMIZATION; SCORING SYSTEM; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

BIOMETRY; FEMALE; HUMANS; MAMMOGRAPHY; MODELS, STATISTICAL; PATIENT SELECTION; PROGNOSIS; RANDOM ALLOCATION; RANDOMIZED CONTROLLED TRIALS;

EID: 25444497480     PISSN: 02776715     EISSN: None     Source Type: Journal    
DOI: 10.1002/sim.2141     Document Type: Article

References (26)

1. Gotzsche PC, Olsen O. Is screening for breast cancer with mammography justifiable? Lancet 2000; 355:129-134.
2. Berger VW, Christophi CA. Randomization technique, allocation concealment, masking, and susceptibility of trials to selection bias. Journal of Modern Applied Statistical Methods 2003; 2(1):80-86.
3. Berger VW. Selection bias and baseline imbalances in randomized trials. Drug Information Journal 2004; 38:1-2.
4. Berger VW, Weinstein S. Ensuring the comparability of comparison groups: is randomization enough? Controlled Clinical Trials 2005; 25:515-524.
5. Berger VW, Exner DV. Detecting selection bias in randomized clinical trials. Controlled Clinical Trials 1999; 20:319-327.
6. Frangakis CE, Rubin DB. Principal stratification in causal inference. Biometrics 2002; 58:21-29.
7. Berger VW, Ivanova A, Deloria-Knoll M. Enhancing allocation concealment through less restrictive randomization procedures. Statistics in Medicine 2003; 22(19):3017-3028.
8. Berger VW, Bears JD. When can a clinical trial be called 'randomized'? Vaccine 2003; 21:468-472.
9. Day S. Blinding or Masking in the Encyclopedia of Biostatistics, Armitage P, Colton T (eds), vol. 1. Wiley: Chichester, 1998; 410-417.
10. Chalmers TC. Discussion of biostatistical collaboration in medical research by Jonas H. Ellenberg. Biometrics 1990; 46:20-22.
11. Tarone RE. The excess of patients with advanced breast cancer in young women screened with mammography in the Canadian National Breast Screening Study. Cancer 1995; 75(4):997-1003.
12. Fergusson D, Aaron SD, Guyatt G, Hebert P. Post-randomization exclusions: the intention to treat principle and excluding patients from analysis. British Medical Journal 2002; 325:652-654.
13. Tukey JW. Tightening the clinical trial. Controlled Clinical Trials 1993; 14(4):266-285.
14. Beach ML, Meier P. Choosing covariates in the analysis of clinical trials. Controlled Clinical Trials 1989; 10:161S-175S.
15. Canner PL. Covariate adjustment of treatment effects in clinical trials. Controlled Clinical Trials 1991; 12:359-366.
16. Moses LE. Measuring effects without randomized trials? Options, problems, challenges. Medical Care 1995; 33(4):AS8-AS14.
17. Olschewski M, Schumacher M, Davis KB. Analysis of randomized and nonrandomized patients in clinical trials using the comprehensive cohort follow-up study design. Controlled Clinical Trials 1992; 13:226-239.
18. Anstrom KJ, Tsiatis AA. Utilizing propensity scores to estimate causal treatment effects with censored time-lagged data. Biometrics 2001; 57:1207-1218.
19. Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika 1983; 70(1):41-55.
20. Green SB, Byar DP. Using observational data from registries to compare treatments: the fallacy of omnimetrics. Statistics in Medicine 1984; 3:361-370.
21. Bird SM. Dissemination of decisions on interim analyses needs wider debate. British Medical Journal 2001; 323:1424.
22. Rosenbaum PR. Conditional permutation tests and the propensity score in observational studies. Journal of the American Statistical Association 1984; 79(387):565-574.
23. Graf E. The propensity score in the analysis of therapeutic studies. Biometrical Journal 1997; 39(3):297-307.
24. Blackwell D, Hodges JL. Design for the control of selection bias. Annals of Mathematical Statistics 1957; 28:449-460.
25. Joffe MM, Rosenbaum PR. Invited commentary: propensity scores. American Journal of Epidemiology 1999; 150(4):327-333.
26. Matts JP, McHugh RB. Conditional Markov chain design for accrual clinical trials. Biometrical Journal 1983; 25:563-577.